Richard Wismayer et al. 2024. Assessment of CDX2 Expression as a Prognostic Marker in Colorectal Adenocarcinoma Patients from Uganda. Medicine and Medical Research: New Perspectives Vol. 2. (Aug. 2024), 67–87. DOI:https://doi.org/10.9734/bpi/mmrnp/v2/1619.